Cellectis S.A. (CLLS) vs Seer, Inc. (SEER)
Cellectis S.A. and Seer, Inc. are both Biotechnology companies. Cellectis S.A. and Seer, Inc. are of similar size ($103.6M and $103.4M). Cellectis S.A. grew revenue faster over the last twelve months: 0.61% against −12.7%. Cellectis S.A. has the higher net margin (−102.3% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 18 metrics below, Cellectis S.A. leads on 10 and Seer, Inc. on 8.
Valuation
Profitability
| Metric | CLLS | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 47.70% | 65.16% |
| Operating margin | (90.88%) | (498.19%) | 0.00% |
| Net margin | (102.34%) | (478.05%) | 0.00% |
| Free cash flow margin | (68.63%) | (309.34%) | 0.00% |
| Return on equity | (94.54%) | (26.45%) | (57.72%) |
| Return on assets | (21.02%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack